Breaking News
Get 40% Off 0
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did. Read how

TipRanks TipRanks

TipRanks's Opinion & Analysis.
Featured here: a complete archive of all posts and research produced by TipRanks, including current material.
UBS, JMP Downgrades ACHN On JNJ Deal By Carly Forster - May 21, 2015

Biotechnology company Achillion Pharmaceuticals (NASDAQ:ACHN) fell about 10% in trading on Wednesday, May 20 following the company’s announcement that it licensed its hepatitis C drug pipeline...

4 Stocks To Watch: BLUE, BBY, CRM, RIG By Sarah Roden - May 21, 2015

Bluebird bio Inc (NASDAQ:BLUE) ares increased 3.8% to $179 in pre-market trading after the company announced it will be presenting data on LentiGlobin, a pipeline product, at the 20th Congress of...

Continue with Google
or
Sign up with Email